# Long‐Term Low‐Dose of Nitrate Administration Improves Antioxidant Defence System in Insulin‐Sensitive Tissues of Type 2 Diabetic Rats

**Authors:** Fatemeh Ghorbani, Majid Shokri, Sajad Jeddi, Asghar Ghasemi

PMC · DOI: 10.1002/edm2.70186 · 2026-02-26

## TL;DR

Long-term low-dose nitrate helps reduce oxidative stress in key tissues of diabetic rats, improving their antioxidant defenses.

## Contribution

This study shows that low-dose nitrate can protect insulin-sensitive tissues from oxidative stress in type 2 diabetes.

## Key findings

- Nitrate increased catalase and restored antioxidant capacity in the liver of diabetic rats.
- Nitrate reduced oxidative damage in muscle and adipose tissue of diabetic rats.
- Positive correlations were found between nitric oxide metabolites and antioxidant markers in multiple tissues.

## Abstract

Type 2 diabetes (T2D) is characterised by increased oxidative stress, which contributes to insulin resistance in insulin‐sensitive tissues. The objective of this study was to determine the antioxidative effects of long‐term nitrate administration in the liver, soleus muscle (SM) and epididymal adipose tissue (eAT) of male rats with T2D.

Rats were divided into four groups (n = 7): Control, Control+Nitrate (C + N), T2D and T2D + Nitrate (T2D + N). T2D was induced using a high‐fat diet followed by a low dose of streptozotocin (30 mg/kg). Nitrate (100 mg/L in drinking water) was administered for 6 months to the nitrate‐treated groups. Liver, SM and eAT were isolated, and tissue levels of catalase (CAT), total antioxidant capacity (TAC), reduced glutathione (GSH), malondialdehyde (MDA) and nitric oxide (NO) metabolites (NOx) were measured at the end of the study.

In the liver, nitrate increased CAT (216%, p < 0.001) and restored reduced TAC and GSH to normal values in rats with T2D. In the SM, nitrate decreased MDA (28%, p = 0.041) and restored reduced CAT to normal value in rats with T2D. In the eAT, nitrate increased CAT (72%, p = 0.046) and TAC (223%, p = 0.018) in rats with T2D. In addition, nitrate‐treated T2D rats had lower MDA (21.6%, p = 0.098) in the liver as well as higher TAC (104%, p = 0.064) in the SM and GSH (163%, p = 0.055) in the eAT; however, these changes were only marginally significant. Positive correlations were observed between NOx and CAT (p < 0.05 in SM and eAT), TAC (p < 0.05 in eAT) and GSH (p < 0.05 in liver, SM and eAT); furthermore, a marginally significant negative correlation was observed between NOx and MDA (p = 0.082 in liver and SM, p = 0.088 in eAT).

Long‐term nitrate administration at low doses has a protective effect against oxidative stress in the liver, SM and eAT of rats with T2D.

Long‐term nitrate administration at low doses has a protective effect against oxidative stress in the liver, soleus muscle (SM) and epididymal adipose tissue (eAT) of male rats with type 2 diabetes (T2D).

## Linked entities

- **Proteins:** Cat (Catalase)
- **Chemicals:** nitrate (PubChem CID 943), malondialdehyde (PubChem CID 10964), glutathione (PubChem CID 124886)
- **Diseases:** type 2 diabetes (MONDO:0005148)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, CAT (catalase) [NCBI Gene 847], Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Tac1 (tachykinin, precursor 1) [NCBI Gene 24806] {aka PPTA3, Ppt5fl, RATPPTA3, TAC}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}
- **Diseases:** cardiovascular disease (MESH:D002318), osteoporosis (MESH:D010024), insulin resistance (MESH:D007333), T2D (MESH:D003924), nephropathy (MESH:D007674), anaemia (MESH:D000743), neuropathy (MESH:D009422), cell (MESH:D002292), mitochondrial dysfunction (MESH:D028361), impaired (MESH:D060825), diabetes (MESH:D003920), retinopathy (MESH:D058437)
- **Chemicals:** H2O2 (MESH:D006861), Ferric (-), sulfanilamide (MESH:D000077145), n-butanol (MESH:D020001), sodium sulfate (MESH:C012036), nitrite (MESH:D009573), TCA (MESH:D014238), carbohydrate (MESH:D002241), MDA (MESH:D008315), tripyridyltriazine (MESH:C002849), citrate (MESH:D019343), GSH (MESH:D005978), lipid (MESH:D008055), acetate (MESH:D000085), glucose (MESH:D005947), TNB (MESH:D014302), ROS (MESH:D017382), sulfuric acid (MESH:C033158), fat (MESH:D005223), Nitrate (MESH:D009566), N (MESH:D009584), FeCl3 (MESH:C024555), Ferrous sulfate (MESH:C020748), sodium pentobarbital (MESH:D010424), water (MESH:D014867), Sodium nitrate (MESH:C031618), TBA (MESH:C029684), STZ (MESH:D013311), acetic acid (MESH:D019342), 5,5'-dithiobis (2-nitrobenzoic acid) (MESH:D004228), potassium dichromate (MESH:D011192), N-(1-naphthyl) ethylenediamine (MESH:C008588), HCl (MESH:D006851), NO (MESH:D009569)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942076/full.md

---
Source: https://tomesphere.com/paper/PMC12942076